Brief: Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile

IGC Pharma

09/07/2024 14:26

July 9 (Reuters) - IGC Pharma Inc  IGC.A :
    * PRECLINICAL ANALYSES OF TGR-63 DEMONSTRATE BLOOD-BRAIN
BARRIER
PERMEABILITY AND SAFETY PROFILE
    * IGC PHARMA INC: PRELIMINARY ANALYSIS CONFIRMS PRESENCE OF
TGR-63
IN BRAIN TISSUE AND SHOWS NO ADVERSE EFFECTS

Source text for Eikon:  ID:nBw6CzL4Ha 
Further company coverage:  IGC.A 

 ((Reuters.Briefs@thomsonreuters.com;))